|

Selexipag Clinical Trials

1 actively recruiting trial

Also known as: Uptravi, oral prostacyclin IP receptor agonist (OPA)

Pipeline

Phase 4: 1

Top Sponsors

  • Sheffield Teaching Hospitals NHS Foundation Trust1

Indications

  • Pulmonary Arterial Hypertension1
  • Heart Disease1

Other1 trial

Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.